YORK, Pa., Nov. 25, 2014 /PRNewswire/ -- Unilife
Corporation (NASDAQ:UNIS, ASX: UNS), a designer, manufacturer and
supplier of injectable drug delivery systems, today announced that
its Chairman and CEO, Alan Shortall,
is scheduled to present at the Piper Jaffray 26th Annual Healthcare
Conference at the New York Palace Hotel at 8:30 a.m. EST on Tuesday,
December 2, 2014.
The conference presentation will be broadcast over the Internet
as a "live" listen only Webcast. To listen, please go to:
http://ir.unilife.com/events.cfm. An archive of the event will also
be available for those unable to listen live.
About Unilife Corporation
Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a U.S. based
developer and commercial supplier of injectable drug delivery
systems. Unilife's portfolio of innovative, differentiated products
includes prefilled syringes with automatic needle retraction, drug
reconstitution delivery systems, auto-injectors, wearable
injectors, ocular delivery systems and novel systems. Products
within each platform are customizable to address specific customer,
drug and patient requirements. Unilife's global headquarters and
manufacturing facilities are located in York, PA. For more information, visit
www.unilife.com or download the Unilife IRapp on your iPhone, iPad
or Android device.
General: UNIS-G
|
Investor / PR
Contacts (US):
|
Analyst
Enquiries:
|
Investor
Contacts (Australia):
|
|
Todd Fromer / Garth
Russell
|
Leigh
Salvo
|
Jeff
Carter
|
|
KCSA Strategic
Communications
|
Westwicke
Partners
|
Unilife
Corporation
|
|
P: + 1
212-682-6300
|
P: + 1
415-513-1281
|
P: + 61 2 8346
6500
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/unilife-to-present-at-the-piper-jaffray-26th-annual-healthcare-conference-on-december-2nd-300001227.html
SOURCE Unilife Corporation